PAUL J SEKHRI
CIK 1264519 · Pres, CEO and Exec Chairperson · last filed 2026-08-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.68M
Companies
9
Total Filings
94
Lifetime Open-Market Net
-$8.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| APMD | Director | 12,500 | — | — | $200.0K | 1 | 2026-08-03 |
| VEEV | Director | 15,191 | $230.47 | $3.50M | -$8.39M | 71 | 2026-06-22 |
| VTVT | Pres, CEO and Exec Chairperson | 5,000 | $35.37 | $176.8K | $83.8K | 4 | 2026-02-18 |
| Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Director | — | $59.98 | — | $0 | 4 | 2024-12-02 |
| Axcella Health Inc. (AXLA) Delisted | Director | — | $0.40 | — | $0 | 1 | 2022-05-25 |
| BiomX Inc. (PHGE.WS) Delisted | Director | 12,500 | $0.01 | $110 | $50.0K | 3 | 2021-07-30 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Director | — | $64.97 | — | $0 | 3 | 2020-01-06 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Director | — | — | — | $0 | 1 | 2016-09-14 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | Director | — | — | — | $0 | 3 | 2010-05-03 |
Recent Filings · Page 8 of 10
94 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-14 | VEEV | Exer (M) | +628 | $0 | EDGAR |
| 2018-06-27 | VEEV | Sell (S) | −1,107 | -$91.7K | EDGAR |
| 2018-06-22 | VEEV | Exer (M) | +601 | $0 | EDGAR |
| 2018-06-15 | VEEV | Grant (A) | — | $0 | EDGAR |
| 2018-03-23 | VEEV | Mixed | −508 | -$83.6K | EDGAR |
| 2018-03-01 | VEEV | Sell (S) | −4,622 | -$300.4K | EDGAR |
| 2018-01-04 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-22 | VEEV | Exer (M) | +601 | $0 | EDGAR |
| 2017-12-08 | VEEV | Mixed | +9,029 | -$590.5K | EDGAR |
| 2017-09-25 | VEEV | Exer (M) | +601 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.